Caxton Associates (New York)’s ScottsMiracle-Gro SMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-41,757
Closed -$1.78M 595
2022
Q3
$1.78M Buy
41,757
+27,842
+200% +$2M 0.24% 38
2022
Q2
$1.1M Buy
+13,915
New +$1.38M 0.11% 102
2022
Q1
Sell
-2,933
Closed -$472K 685
2021
Q4
$472K Buy
+2,933
New +$454K 0.05% 290
2018
Q3
Sell
-3,362
Closed -$280K 525
2018
Q2
$280K Buy
+3,362
New +$281K 0.01% 314
2017
Q4
Sell
-6,000
Closed -$584K 512
2017
Q3
$584K Buy
+6,000
New +$569K 0.02% 281

Other funds holding SMG

Caxton Associates (New York)'s SMG Position: Q4 2022 in Review

Caxton Associates (New York) sold out of ScottsMiracle-Gro (SMG) in Q4 2022, closing a stake of 41,757 shares — an estimated $1.78M sold.

Caxton Associates (New York) first reported a position in SMG in Q3 2017 and held it in 5 quarters. The position peaked at $1.78M in Q3 2022. 426 funds tracked by Wall St. Rank hold SMG as of Q4 2022.

  • Caxton Associates (New York) reported no remaining ScottsMiracle-Gro position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 41,757 ScottsMiracle-Gro shares in Q4 2022, an estimated $1.78M.
  • Caxton Associates (New York) first reported a position in ScottsMiracle-Gro in Q3 2017 and held it in 5 quarters.
  • Caxton Associates (New York)'s ScottsMiracle-Gro position peaked at $1.78M in Q3 2022.
  • 426 funds tracked by Wall St. Rank held ScottsMiracle-Gro as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.